Literature DB >> 2276990

Thermophilic campylobacters in surface waters around Lancaster, UK: negative correlation with Campylobacter infections in the community.

K Jones1, M Betaieb, D R Telford.   

Abstract

The incidence of campylobacter enteritis in Lancaster City Health Authority is three times the UK average for similar sizes of population and has marked seasonal peaks in May and June. Environmental monitoring of surface waters around Lancaster showed that thermophilic campylobacters were absent from drinking water from the fells and from the clean upper reaches of the River Conder but were present in the main rivers entering Morecambe Bay, the lower reaches of the River Conder, the Lancaster canal, and seawater from the Lune estuary and Morecambe Bay. All the surface waters tested showed the same seasonality, namely, higher numbers in the winter months and low numbers or none in May, June and July. The absence of thermophilic campylobacters in the summer months may be due to high sunshine levels because experiments on the effects of light showed that campylobacters in sewage effluent and seawater were eliminated within 60 and 30 min of daylight respectively but survived for 24 h in darkness. As the concentrations of campylobacters in surface waters were at their lowest precisely at the time of peak infections in the community it is unlikely that surface waters form Lancaster's reservoir of campylobacter infection for the community.

Entities:  

Mesh:

Year:  1990        PMID: 2276990     DOI: 10.1111/j.1365-2672.1990.tb01573.x

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN: 0021-8847


  8 in total

1.  Prevalence and genetic diversity of Campylobacter spp. in environmental water samples from a 100-square-kilometer predominantly dairy farming area.

Authors:  R Kemp; A J H Leatherbarrow; N J Williams; C A Hart; H E Clough; J Turner; E J Wright; N P French
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

2.  Campylobacter jejuni in black-headed gulls (Larus ridibundus): prevalence, genotypes, and influence on C. jejuni epidemiology.

Authors:  T Broman; H Palmgren; S Bergström; M Sellin; J Waldenström; M-L Danielsson-Tham; B Olsen
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

3.  Protozoan Acanthamoeba polyphaga as a potential reservoir for Campylobacter jejuni.

Authors:  Diana Axelsson-Olsson; Jonas Waldenström; Tina Broman; Björn Olsen; Martin Holmberg
Journal:  Appl Environ Microbiol       Date:  2005-02       Impact factor: 4.792

4.  Acanthamoeba-Campylobacter coculture as a novel method for enrichment of Campylobacter species.

Authors:  Diana Axelsson-Olsson; Patrik Ellström; Jonas Waldenström; Paul D Haemig; Lars Brudin; Björn Olsen
Journal:  Appl Environ Microbiol       Date:  2007-09-14       Impact factor: 4.792

5.  Molecular epidemiology of Campylobacter jejuni populations in dairy cattle, wildlife, and the environment in a farmland area.

Authors:  Patrick S L Kwan; Mishele Barrigas; Frederick J Bolton; Nigel P French; Peter Gowland; Richard Kemp; Howard Leatherbarrow; Mathew Upton; Andrew J Fox
Journal:  Appl Environ Microbiol       Date:  2008-06-27       Impact factor: 4.792

6.  Novel clonal complexes with an unknown animal reservoir dominate Campylobacter jejuni isolates from river water in New Zealand.

Authors:  P E Carter; S M McTavish; H J L Brooks; D Campbell; J M Collins-Emerson; A C Midwinter; N P French
Journal:  Appl Environ Microbiol       Date:  2009-07-31       Impact factor: 4.792

7.  Campylobacter jejuni multilocus sequence types in humans, northwest England, 2003-2004.

Authors:  Will Sopwith; Andrew Birtles; Margaret Matthews; Andrew Fox; Steven Gee; Michael Painter; Martyn Regan; Qutub Syed; Eric Bolton
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

8.  Pathogen survival trajectories: an eco-environmental approach to the modeling of human campylobacteriosis ecology.

Authors:  Chris Skelly; Phil Weinstein
Journal:  Environ Health Perspect       Date:  2003-01       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.